ArriVent Biopharma funding ArriVent Biopharma funding profile: 50M total raised. Latest round: Series A. Backed by Hillhouse Capital Group, Boyu/Zoo Capital, OrbiMed. Headquarters: null InvestorsHillhouse Capital GroupBoyu/Zoo CapitalOrbiMedOctagon Capital AdvisorsLyra Capital Fundraising guidesChristian Gaiser: Lessons From Raising 50M+ Across Two StartupsCybersecurity Due Diligence For M&A: A Tactical GuideA Founder's Guide to Equity Incentive Plans More company funding profilesArrivo BioVentures LLCArrowArrived Homes Browse the company funding database · Browse investors · Fundraising library All companies by funding raisedCompanies page 2San Francisco startupsNew York startupsLondon startupsBoston startupsAustin startupsSeed stage companiesSeries A stage companiesSeries B stage companiesSeries C stage companiesGrowth stage companiesIpo stage companiesStartups funded in 2026
